Bladder cancer drug trial halted before it began
NCT ID NCT07313891
First seen Jan 09, 2026 · Last updated Jun 16, 2026 · Updated 26 times
Summary
This study was designed to test whether a new drug called NDV-01 (a slow-release combination of two chemotherapy medicines) could prevent bladder cancer from coming back after surgery. It planned to enroll 302 people with intermediate-risk non-muscle invasive bladder cancer. However, the trial was withdrawn before any participants were enrolled, so no results are available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UROTHELIAL CARCINOMA BLADDER are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.